NASDAQ:QTRX Quanterix (QTRX) Stock Price, News & Analysis $11.99 -0.26 (-2.12%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$11.87▼$12.7450-Day Range$10.92▼$16.3652-Week Range$10.50▼$29.70Volume261,595 shsAverage Volume398,541 shsMarket Capitalization$460.18 millionP/E RatioN/ADividend YieldN/APrice Target$24.80 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Quanterix alerts: Email Address Quanterix MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.80 Rating ScoreUpside/Downside106.8% Upside$24.80 Price TargetShort InterestBearish5.79% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.88) to ($0.87) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.78 out of 5 starsMedical Sector589th out of 910 stocksAnalytical Instruments Industry19th out of 26 stocks 3.4 Analyst's Opinion Consensus RatingQuanterix has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageQuanterix has only been the subject of 3 research reports in the past 90 days.Read more about Quanterix's stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted5.79% of the float of Quanterix has been sold short.Short Interest Ratio / Days to CoverQuanterix has a short interest ratio ("days to cover") of 4.3.Change versus previous monthShort interest in Quanterix has recently decreased by 2.42%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldQuanterix does not currently pay a dividend.Dividend GrowthQuanterix does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for QTRX. Previous Next 2.2 News and Social Media Coverage News SentimentQuanterix has a news sentiment score of 0.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Quanterix this week, compared to 3 articles on an average week.Search InterestOnly 1 people have searched for QTRX on MarketBeat in the last 30 days. This is a decrease of -88% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Quanterix insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 6.90% of the stock of Quanterix is held by insiders.Percentage Held by Institutions86.48% of the stock of Quanterix is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Quanterix's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Quanterix are expected to grow in the coming year, from ($0.88) to ($0.87) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Quanterix is -12.49, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Quanterix is -12.49, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioQuanterix has a P/B Ratio of 1.31. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Quanterix's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Golden CrestBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security.>> Get Your FREE Wealth Protection Guide << About Quanterix Stock (NASDAQ:QTRX)Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.Read More QTRX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart QTRX Stock News HeadlinesAugust 30, 2024 | finance.yahoo.comQuanterix to Participate at the Morgan Stanley 22nd Annual Global Healthcare ConferenceAugust 26, 2024 | seekingalpha.comQuanterix Corporation: Still Struggling To Gain TractionSeptember 7, 2024 | Porter & Company (Ad)Why billionaires are wiring money to abandoned towns A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most valuable economic hubs – the beating heart of a new multi-billion-dollar revolution. August 20, 2024 | uk.finance.yahoo.comHow labor data revisions could shift Fed's policy stanceAugust 20, 2024 | uk.finance.yahoo.comGold prices could hit $2600 by year end: UBSAugust 20, 2024 | stockhouse.comJeffrey Elliott Appointed to Quanterix's Board of DirectorsAugust 20, 2024 | finance.yahoo.comMasoud Toloue Bought 11% More Shares In QuanterixAugust 19, 2024 | finance.yahoo.comJeffrey Elliott Appointed to Quanterix’s Board of DirectorsSeptember 7, 2024 | Porter & Company (Ad)Why billionaires are wiring money to abandoned towns A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most valuable economic hubs – the beating heart of a new multi-billion-dollar revolution. August 19, 2024 | finance.yahoo.comQTRX Sep 2024 12.500 put (QTRX240920P00012500)August 15, 2024 | finance.yahoo.comInsider Buying: President & CEO Masoud Toloue Acquires Shares of Quanterix Corp (QTRX)August 12, 2024 | markets.businessinsider.comScotiabank Keeps Their Buy Rating on Quanterix (QTRX)August 11, 2024 | finance.yahoo.comQuanterix Corporation (NASDAQ:QTRX) Just Reported, And Analysts Assigned A US$22.00 Price TargetAugust 9, 2024 | seekingalpha.comQuanterix Corporation (QTRX) Q2 2024 Earnings Call TranscriptAugust 9, 2024 | finance.yahoo.comQuanterix Releases Financial Results for the Second Quarter of 2024August 9, 2024 | markets.businessinsider.comHold Rating on Quanterix Amid Modest Sales Performance and Market UncertaintyAugust 8, 2024 | investorplace.comQTRX Stock Earnings: Quanterix Beats EPS, Beats Revenue for Q2 2024August 7, 2024 | finance.yahoo.comQuanterix Presenting at Canaccord Genuity 44th Annual Growth ConferenceSee More Headlines Receive QTRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Quanterix and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/08/2024Today9/07/2024Next Earnings (Estimated)11/04/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Analytical instruments Sub-IndustryMeasuring And Control Equipment Current SymbolNASDAQ:QTRX CUSIPN/A CIK1503274 Webwww.quanterix.com Phone(617) 301-9400FaxN/AEmployees460Year FoundedN/APrice Target and Rating Average Stock Price Target$24.80 High Stock Price Target$32.00 Low Stock Price Target$15.00 Potential Upside/Downside+106.8%Consensus RatingModerate Buy Rating Score (0-4)2.80 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($0.96) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-32,330,000.00 Net Margins-30.71% Pretax Margin-30.21% Return on Equity-11.52% Return on Assets-9.47% Debt Debt-to-Equity RatioN/A Current Ratio9.74 Quick Ratio8.99 Sales & Book Value Annual Sales$122.37 million Price / Sales3.76 Cash FlowN/A Price / Cash FlowN/A Book Value$9.17 per share Price / Book1.31Miscellaneous Outstanding Shares38,380,000Free Float35,629,000Market Cap$460.18 million OptionableOptionable Beta1.36 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesDr. Masoud Toloue Ph.D. (Age 43)President, CEO & Director Comp: $957.03kDr. David R. Walt Ph.D. (Age 71)Co-Founder, Chairman of Scientific Advisory Board & Independent Director Comp: $47.25kDr. Mark T. Roskey Ph.D. (Age 64)Senior Vice President of Strategic Partnerships Comp: $495.03kMr. Michael A. Doyle (Age 68)Executive Director of Finance Comp: $570.14kMs. Vandana Sriram CPA (Age 50)Chief Financial Officer Mr. Daniel Pikora (Age 48)Chief Operating Officer Dr. David C. Duffy Ph.D. (Age 53)Senior VP of Research & Development and CTO Comp: $299.05kMs. Alexandra PhillipsSenior VP & Chief Information OfficerMs. Laurie A. Churchill (Age 53)Senior VP, General Counsel & Secretary David PanzerellaVice President of SalesMore ExecutivesKey CompetitorsPacific Biosciences of CaliforniaNASDAQ:PACBFluidigmNASDAQ:FLDMHarvard BioscienceNASDAQ:HBIOTranscatNASDAQ:TRNSStandard BioToolsNASDAQ:LABView All CompetitorsInsiders & InstitutionsAlgert Global LLCBought 78,337 shares on 8/16/2024Ownership: 0.204%Millennium Management LLCSold 1,430,348 shares on 8/15/2024Ownership: 2.175%Marathon Capital ManagementBought 18,425 shares on 8/15/2024Ownership: 0.358%Deerfield Management Company L.P. Series CBought 21,461 shares on 8/15/2024Ownership: 0.056%Torno Capital LLCSold 22,500 shares on 8/14/2024Ownership: 0.000%View All Insider TransactionsView All Institutional Transactions QTRX Stock Analysis - Frequently Asked Questions How have QTRX shares performed this year? Quanterix's stock was trading at $27.34 at the beginning of the year. Since then, QTRX shares have decreased by 56.1% and is now trading at $11.99. View the best growth stocks for 2024 here. How were Quanterix's earnings last quarter? Quanterix Co. (NASDAQ:QTRX) announced its earnings results on Thursday, August, 8th. The company reported ($0.25) earnings per share for the quarter, missing analysts' consensus estimates of ($0.23) by $0.02. The firm had revenue of $34.38 million for the quarter, compared to analyst estimates of $34.19 million. Quanterix had a negative trailing twelve-month return on equity of 11.52% and a negative net margin of 30.71%. What is Kevin Hrusovsky's approval rating as Quanterix's CEO? 15 employees have rated Quanterix Chief Executive Officer Kevin Hrusovsky on Glassdoor.com. Kevin Hrusovsky has an approval rating of 70% among the company's employees. When did Quanterix IPO? Quanterix (QTRX) raised $50 million in an initial public offering on Thursday, December 7th 2017. The company issued 3,300,000 shares at $14.00-$16.00 per share. J.P. Morga and Leerink Partners acted as the underwriters for the IPO and BTIG and Evercore ISI were co-managers. Who are Quanterix's major shareholders? Quanterix's top institutional investors include Dimensional Fund Advisors LP (2.37%), Millennium Management LLC (2.18%), Easterly Investment Partners LLC (1.81%) and Emerald Advisers LLC (1.78%). Insiders that own company stock include David R Walt, E Kevin Hrusovsky, Masoud Toloue, Michael A Doyle, John J Fry, Dawn Mattoon, William P Donnelly, Mark T Roskey and David C Duffy. View institutional ownership trends. How do I buy shares of Quanterix? Shares of QTRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Quanterix own? Based on aggregate information from My MarketBeat watchlists, some other companies that Quanterix investors own include Editas Medicine (EDIT), Novavax (NVAX), Akoustis Technologies (AKTS), Advanced Micro Devices (AMD), CRISPR Therapeutics (CRSP), Walt Disney (DIS) and Illumina (ILMN). This page (NASDAQ:QTRX) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredMy grim warning about AI stocksToday, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quanterix Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Quanterix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.